XML 34 R12.htm IDEA: XBRL DOCUMENT v3.3.1.900
Earnings per Share
9 Months Ended
Oct. 31, 2015
Earnings Per Share [Abstract]  
Earnings per Share
4.            Earnings per Share

The following tables show the computation of basic and diluted earnings per common share from continuing operations for each period presented (in thousands, except per share amounts):
 
Three Months Ended
 
Nine Months Ended
 
October 31, 2015
 
November 1, 2014
 
October 31, 2015
 
November 1, 2014
Basic EPS from continuing operations:
 
 
 
 
 
 
 
Loss from continuing operations
$
(10,183
)
 
$
(5,107
)
 
$
(17,205
)
 
$
(5,961
)
Less: Allocation of earnings to participating securities

 

 

 

Net loss from continuing operations allocated to common shares
(10,183
)
 
(5,107
)
 
(17,205
)
 
(5,961
)
 
 
 
 
 
 
 
 
Basic weighted average shares outstanding
32,017

 
31,794

 
31,917

 
31,681

Basic EPS from continuing operations
$
(0.32
)
 
$
(0.16
)
 
$
(0.54
)
 
$
(0.19
)
 
 
 
 
 
 
 
 
 
Three Months Ended
 
Nine Months Ended
 
October 31, 2015
 
November 1, 2014
 
October 31, 2015
 
November 1, 2014
Diluted EPS from continuing operations:
 

 
 

 
 
 
 
Loss from continuing operations
$
(10,183
)
 
$
(5,107
)
 
$
(17,205
)
 
$
(5,961
)
Less: Allocation of earnings to participating securities

 

 

 

Net loss from continuing operations allocated to common shares
(10,183
)
 
(5,107
)
 
(17,205
)
 
(5,961
)
 
 
 
 
 
 
 
 
Basic weighted average shares outstanding
32,017

 
31,794

 
31,917

 
31,681

Add: Dilutive effect of stock awards

 

 

 

Diluted weighted average shares outstanding
32,017

 
31,794

 
31,917

 
31,681

Diluted EPS from continuing operations
$
(0.32
)
 
$
(0.16
)
 
$
(0.54
)
 
$
(0.19
)

 
The number of shares attributable to stock options, SARs and non-vested stock grants that would have been considered dilutive securities, but were excluded from the calculation of diluted earnings per common share because the effect was anti-dilutive were as follows (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
October 31, 2015
 
November 1, 2014
 
October 31, 2015
 
November 1, 2014
Number of anti-dilutive shares due to net loss for the period
9

 
50

 
52

 
90

Number of anti-dilutive SARs due to exercise price greater than average market price of our common stock
224


240


158


246